tiprankstipranks
Clover Biopharmaceuticals Ltd. (HK:2197)
:2197
Hong Kong Market
2197
Clover Biopharmaceuticals Ltd.
RESEARCH TOOLSreports
Want to see HK:2197 full AI Analyst Report?

Clover Biopharmaceuticals Ltd. (2197) Financial Statements

1 Followers

Clover Biopharmaceuticals Ltd. Financial Overview

Clover Biopharmaceuticals Ltd.'s market cap is currently HK$3.86B. The company's EPS TTM is HK$-0.092; its P/E ratio is -13.26; Clover Biopharmaceuticals Ltd. is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 3.41M¥ 38.42M¥ 39.26M¥ 0.00¥ 0.00
Gross Profit¥ -23.85M¥ -672.94M¥ 24.24M¥ -475.64M¥ -66.27M
Operating Income¥ -247.75M¥ -951.21M¥ -2.58B¥ -2.35B¥ -2.24B
EBITDA¥ -221.24M¥ -916.54M¥ -45.07M¥ -2.37B¥ -2.23B
Net Income¥ -199.78M¥ -903.43M¥ -138.54M¥ -2.45B¥ -6.02B
Balance Sheet
Cash & Short-Term Investments¥ 286.15M¥ 427.53M¥ 766.26M¥ 1.64B¥ 2.87B
Total Assets¥ 458.12M¥ 812.74M¥ 2.10B¥ 4.69B¥ 5.35B
Total Debt¥ 10.62M¥ 89.64M¥ 334.45M¥ 354.37M¥ 67.92M
Net Debt¥ -260.90M¥ -311.60M¥ -401.41M¥ -1.25B¥ -2.70B
Total Liabilities¥ 2.26B¥ 2.45B¥ 2.83B¥ 5.36B¥ 4.13B
Stockholders' Equity¥ -1.80B¥ -1.64B¥ -732.83M¥ -668.14M¥ 1.22B
Cash Flow
Free Cash Flow¥ -190.55M¥ -290.11M¥ -737.05M¥ -1.80B¥ -998.07M
Operating Cash Flow¥ -190.52M¥ -288.49M¥ -727.88M¥ -1.69B¥ -917.75M
Investing Cash Flow¥ -11.69K¥ 3.17M¥ -6.16M¥ -37.51M¥ 112.12M
Financing Cash Flow¥ -76.59M¥ -51.50M¥ -142.41M¥ 483.14M¥ 3.06B
Currency in CNY

Clover Biopharmaceuticals Ltd. Earnings and Revenue History

Income Statement >

Clover Biopharmaceuticals Ltd. Debt to Assets

Balance Sheet >

Clover Biopharmaceuticals Ltd. Cash Flow

Cash Flow >

Clover Biopharmaceuticals Ltd. Forecast EPS vs Actual EPS

Earnings >